Diamonds and Dogs
Abbott Laboratories (ABT) surges after the company unveiled a coronavirus test that can tell if someone is infected in as little as five minutes. Abbott's stock is up 7% as the medical-device maker plans to supply 50,000 tests a day starting April 1. The molecular test looks for fragments of the coronavirus genome, which can quickly be detected when present at high levels. Abbott has received emergency use authorization from the U.S. Food and Drug Administration.
Johnson & Johnson (JNJ) jumping on news of the company identified a leading coronavirus vaccine candidate that could result in more than a billion doses available to address the global pandemic. The stock is up 7% as Johnson & Johnson said the vaccine was developed in partnership with Jansen Pharmaceuticals and the U.S Biomedical Advanced Research and Development Authority and that it hopes to initiate human trials for the lead vaccine candidate by September at the latest. The company also said it expects the first batch could be available for emergency use in early 2021.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.